Clinical Trials Directory

Trials / Completed

CompletedNCT01122797

Influence of Adiponutrin in Chronic Liver Disease

Study of Metabolism Influence in Human Alcoholic Liver Disease

Status
Completed
Phase
Study type
Observational
Enrollment
658 (actual)
Sponsor
Erasme University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Increasing evidence attests the influence of multiple metabolic genetic risk factors in the progression of alcoholic liver disease. Deleterious pathways involved in metabolism such as lipid peroxidation and cytokines have been implicated in promoting inflammation leading to fibrosis increase and liver injury progression. The aim of this study was to assess the role of rs738409 single nucleotide polymorphism in the PNPLA3 gene in alcoholic liver disease patients.

Conditions

Timeline

Start date
2003-01-01
Primary completion
2010-01-01
Completion
2010-03-01
First posted
2010-05-13
Last updated
2010-05-13

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01122797. Inclusion in this directory is not an endorsement.

Influence of Adiponutrin in Chronic Liver Disease (NCT01122797) · Clinical Trials Directory